Search Within

Komal Lachhman Jhaveri

Formats
  1. Meeting Abstract (120)
  2. Journal Article (89)
  3. Review (7)
  4. Editorial (2)
  5. Correspondence (1)
  6. Guidelines (1)
Groups
  1. Breast Medicine Service (220)
  2. Department of Medicine (220)
  3. Solid Tumor Oncology Division (220)
  4. GSK Faculty (58)
  5. Survivorship Research (47)
  6. Epidemiology and Biostatistics (44)

More Groups

People
  1. Shanu Modi (35)
  2. Sarat Chandarlapaty (28)
  3. Pedram Razavi (25)
  4. Clifford Hudis (24)
  5. Sujata Patil (22)
  6. Gary Ulaner (18)

More People

Years
  1. 2025 (26)
  2. 2024 (34)
  3. 2023 (17)
  4. 2022 (24)
  5. 2021 (26)
  6. 2020 (28)

More Years

Publications
  1. Journal of Clinical Oncology (66)
  2. Cancer Research (33)
  3. Annals of Oncology (22)
  4. Clinical Cancer Research (10)
  5. European Journal of Cancer (5)
  6. New England Journal of Medicine (5)

More Publications

Publishers
  1. American Society of Clinical Oncology (69)
  2. American Association for Cancer Research (47)
  3. Oxford University Press (23)
  4. Elsevier Inc. (18)
  5. Springer (7)
  6. Nature Publishing Group (6)

More Publishers

Results (220)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Balancing the risks and benefits of extended adjuvant endocrine therapy [Interview]
    Journal Article

    Jhaveri, K. L.
    Clinical Advances in Hematology & Oncology (2019)

    Fulltext@MSK | Save
  • Targeting apoptosis: A new paradigm for the treatment of estrogen receptor-positive breast cancer
    Editorial

    Drago, J. Z.; Chandarlapaty, S.; Jhaveri, K.
    Cancer Discovery (2019)

    Fulltext@MSK | Save
  • PRECISE: A clinical-grade automated molecular eligibility screening and just-in-time (JIT) physician decision support solution for molecularly-selected oncology trials
    Meeting Abstract

    Tao, J.; Eubank, M. H.; Pamer, E.; Cangemi, N. A.; Drilon, A. E.; Harding, J. J.; Schram, A. M.; Smyth, L. M.; Jhaveri, K. L.; Li, B. T.; more...
    Journal of Clinical Oncology (2018)

    Fulltext@MSK | Save
  • A phase I basket study of the PI3K inhibitor taselisib (GDC-0032) in PIK3CA-mutated locally advanced or metastatic solid tumors
    Meeting Abstract

    Jhaveri, K.; Juric, D.; Saura, C.; Cervantes, A.; Melnyk, A.; Patel, M. R.; Oliveira, M.; Gambardella, V.; Ribrag, V.; Ma, C. X.; more...
    Cancer Research (2018)

    Fulltext@MSK | Save
  • Co-targeting ER and FGFR in patients with ER+/HER2- FGFR amplified (amp) metastatic breast cancer (MBC)
    Meeting Abstract

    Jhaveri, K.; Syed, U.; Wong, S.; D'Andrea, G.; Lake, D.; Goldfarb, S.; Gajria, D.; Ligresti, L.; Rogado, A.; Reis-Filho, J.; more...
    European Journal of Cancer (2018)

    Fulltext@MSK | Save
  • Ado-trastuzumab emtansine (T-DM1) in patients (pts) with HER2 amplified (amp) tumors excluding breast and gastric/gastro-esophageal junction (GEJ) adenocarcinomas: Results from the National Cancer Institute (NCI) Molecular Analysis for Therapy Choice (MATCH) trial
    Meeting Abstract

    Jhaveri, K. L.; Makker, V.; Wang, X. V.; Chen, A. P.; Flaherty, K.; Conley, B. A.; O'Dwyer, P. J.; Williams, P. M.; Hamilton, S. R.; Harris, L.; more...
    Journal of Clinical Oncology (2018)

    Fulltext@MSK | Save
  • Circulating biomarkers and resistance to endocrine therapy in metastatic breast cancers: Correlative results from AZD9496 Oral SERD phase I trial
    Journal Article

    Paoletti, C.; Schiavon, G.; Dolce, E. M.; Darga, E. P.; Hedley Carr, T.; Geradts, J.; Hoch, M.; Klinowska, T.; Lindemann, J.; Marshall, G.; more...
    Clinical Cancer Research (2018)

    Fulltext@MSK | Save
  • The genomic landscape of endocrine-resistant advanced breast cancers
    Journal Article

    Razavi, P.; Chang, M. T.; Xu, G.; Bandlamudi, C.; Ross, D. S.; Vasan, N.; Cai, Y.; Bielski, C. M.; Donoghue, M. T. A.; Jonsson, P.; more...
    Cancer Cell (2018)

    Fulltext@MSK | Save
  • A first-in-human study of the new oral selective estrogen receptor degrader AZD9496 for ER(+)/HER2(-) advanced breast cancer
    Journal Article

    Hamilton, E. P.; Patel, M. R.; Armstrong, A. C.; Baird, R. D.; Jhaveri, K.; Hoch, M.; Klinowska, T.; Lindemann, J. P. O.; Morgan, S. R.; Schiavon, G.; more...
    Clinical Cancer Research (2018)

    Fulltext@MSK | Save
  • First-in-human human epidermal growth factor receptor 2-targeted imaging using (89)Zr-Pertuzumab PET/CT: Dosimetry and clinical application in patients with breast cancer
    Journal Article

    Ulaner, G. A.; Lyashchenko, S. K.; Riedl, C.; Ruan, S.; Zanzonico, P. B.; Lake, D.; Jhaveri, K.; Zeglis, B.; Lewis, J. S.; O'Donoghue, J. A.
    Journal of Nuclear Medicine (2018)

    Fulltext@MSK | Save